US Stock MarketDetailed Quotes

ARTV Artiva Biotherapeutics

Watchlist
  • 9.970
  • -1.070-9.69%
Close Dec 18 16:00 ET
  • 10.470
  • +0.500+5.02%
Pre 05:33 ET
242.16MMarket Cap-3.95P/E (TTM)

About Artiva Biotherapeutics Company

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Company Profile

SymbolARTV
Company NameArtiva Biotherapeutics
Listing DateJul 19, 2024
Issue Price12.00
Founded2019
CEODr. Fred Aslan, M.D.
MarketNASDAQ
Employees81
Fiscal Year Ends12-31
Address5505 Morehouse Drive,Suite 100
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-267-4467

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Fred Aslan, M.D.
  • President, Chief Executive Officer and Director
  • 1.11M
  • Neha Krishnamohan
  • Executive Vice President, Corporate Development, Chief Financial Officer and Principal Accounting Officer
  • --
  • Jennifer Kinsbruner Bush
  • Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer
  • 725.83K
  • Thorsten Graef, M.D.,PhD
  • Chief Medical Officer
  • --
  • Christopher Horan
  • Chief Technical Operations Officer
  • 726.90K
  • Dr. Heather Raymon, PhD
  • Senior Vice President, Research and Early Development
  • --
  • Dr. Brian Daniels,M.D.
  • Chairman of the Board
  • --
  • Dr. Diego Miralles, M.D.
  • Director
  • --
  • Dr. Alison Moore, PhD
  • Director
  • --
  • Yong-Jun Huh
  • Director
  • --
  • James Jong-eun Park
  • Director
  • --
  • Elizabeth L. Hougen
  • Independent Director
  • --
  • Dr. Laura Stoppel, PhD
  • Independent Director
  • --
  • Dr. Laura Bessen, M.D.
  • Independent Director
  • --
  • Dr. Yvonne Yamanaka, PhD
  • Independent Director
  • --
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.